ECLIPSE BIOINNOVATIONS, INC. — Form D
ECLIPSE BIOINNOVATIONS, INC. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-10. The offering totals $15.0M, of which $12.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-09-10
- Form: D
- Accession: 0001881936-21-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $12.0M
- Remaining: $3.0M
- Investors: 10
- Date of first sale: 2021-08-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-412955
Issuer
- Name: ECLIPSE BIOINNOVATIONS, INC.
- CIK: 0001881936
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 5770 Oberlin Dr., SAN DIEGO, CA, 92121
- Phone: (858) 768-0699
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Hallie L Kuhn | Director | San Diego, CA |
| Eric L Van Nostrand | Director | San Diego, CA |
| Daniel L Vasella | Director | San Diego, CA |
| Eugene W Yeo | Director | San Diego, CA |
| Peter Chu | Director | NEW YORK, NY |
| Peter Chu | Executive Officer | NEW YORK, NY |
| Daniel Vasella | Director | San Diego, CA |
| Edmond Wong | Director | San Diego, CA |
| Eugene Yeo | Director | MADISON, WI |
Other filings by this issuer (1)
More